Gentoo: GLSA-202304-12 Normal: ADOdb Code Vulnerability Exploit
gentoo
January 24, 2017
Multiple vulnerabilities have been found in ADOdb, all of which could allow remote attackers to execute arbitrary code.
Summary
Multiple vulnerabilities have been discovered in ADOdb. Please review the CVE identifiers referenced below for details.
Topics Covered
Resolution
All ADOdb users should upgrade to the latest version:
# emerge --sync
# emerge --ask --oneshot --verbose ">=dev-php/adodb-5.20.9"
References
[ 1 ] CVE-2016-4855 http://nvd.nist.gov/nvd.cfm?cvename=CVE-2016-4855 [ 2 ] CVE-2016-7405 http://nvd.nist.gov/nvd.cfm?cvename=CVE-2016-7405
Availability
This GLSA and any updates to it are available for viewing at
the Gentoo Security Website:
https://security.gentoo.org/glsa/201701-59
style>.gentoo_availability{display:block;}
Concerns
Security is a primary focus of Gentoo Linux and ensuring the confidentiality and security of our users' machines is of utmost importance to us. Any security concerns should be addressed to security@gentoo.org or alternatively, you may file a bug at https://bugs.gentoo.org.
PREVIOUS
NEXT
Severity: Normal
Title: ADOdb: Multiple vulnerabilities
Date: January 24, 2017
Bugs: #604714
ID: 201701-59
Topics Covered
Background
ADOdb is an abstraction library for PHP creating a common API for a
wide range of database backends.
Get the latest News and Insights
Get the latest Linux and open source security news straight to your inbox.
Affected Packages
-------------------------------------------------------------------
Package / Vulnerable / Unaffected
-------------------------------------------------------------------
1 dev-php/adodb < 5.20.9 >= 5.20.9
Impact
=====
A remote attacker, through the use of SQL injection or Cross Site
Scripting (XSS) attacks, could execute arbitrary code.
Workaround
There is no known workaround at this time.
Related News
Powered By
Linux Security - Your source for Top Linux News, Advisories, HOWTOs and Feature Releases
QUICK LINKS
subscribe to newsletters!
Like staying secure? So do we.
Sign up for updates, tips, and alerts!